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differentiation with Flexner–Wintersteiner rosettes and
endocrine features with antidiuretic hormone (ADH) produc-
tion before treatment, and presented mature transformation
to ganglioneuroma after chemoradiotherapy. Although ONB
with various histological subtypes is known, no case of gan-
glioneural maturation without original immature components
has been reported.
CLINICAL SUMMARY
A 56-year-old man was admitted with symptoms of recurrent
epistaxis and nasal obstruction over 3 months and occa-
sional headaches in the right frontal region. Computed
tomography (CT) and magnetic resonance imaging (MRI)
(Fig. 1) revealed a large tumor occupying the right ethmoidal
sinus with extension to the right sphenoidal sinus and both
maxillary sinuses, and reaching the anterior cranial fossa and
orbital medial wall that had bony erosion. A biopsy of the
tumor was performed and histological diagnosis of ONB was
established. After admission, he exhibited consciousness
disturbance due to a syndrome of inappropriate secretion of
antidiuretic hormone (SIADH) and hyponatremia. After an
initial dose of 16 Gy external irradiation to the frontal lesion,
radiotherapy was interrupted because of cervical lymph node
metastasis. The patient was treated with five courses of sys-
temic chemotherapy (carboplatin and etoposide). After the
tumor had decreased in size, it was surgically removed by
radical craniofacial resection followed by g-knife irradiation of
the intracranial residual tumor. However, mediastinal metas-
tasis was found and the patient died of aspiration pneumonia
3 months after the operation. An autopsy was not performed.
PATHOLOGICAL FINDINGS
The first biopsy specimen, 10 ¥ 5 ¥ 5 mm in size, was taken
from the nasal cavity. The tumor was highly cellular with
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We report a 56-year-old man in whom an olfactory neu-
roblastoma with epithelial and endocrine differentiation 
transformed into a mature ganglioneuroma after chemora-
diotherapy. The tumor arising from the sphenoidal and max-
illary sinuses showed rapid growth into the frontal lobe and
metastasis to the cervical lymph nodes. The patient showed
signs of a syndrome of inappropriate secretion of antidi-
uretic hormone (SIADH). A radical craniofacial resection of
the primary tumor was performed after 16 Gy of local irradi-
ation and systemic chemotherapy. Three months after the
operation, the patient died of mediastinal metastasis. The
biopsy before chemoradiotherapy showed a neuroblastoma
with Homer–Wright rosettes, fibrillary matrix, Flexner–
Wintersteiner rosettes and antidiuretic hormone produc-
tion. After chemoradiotherapy, the histology changed to that
of a ganglioneuroma consisting of large ganglion cells and
Schwann cells without immature neuroblastoma compo-
nents. Although transformation to ganglioneuroma in an
adrenal neuroblastoma is common, an olfactory neuroblas-
toma showing ganglioneuronal maturation after chemo-
radiotherapy has not been reported. The pluripotent
progenitor cells of the olfactory neurons may be the origin
and their existence explains why various neoplasms with
neuronal and epithelial differentiation arise from the olfac-
tory mucosa.
Key words: antidiuretic hormone, apoptosis, esthesioneuroep-
ithelioma, ganglioneuroma, olfactory neuroblastoma, stem cell,
transformation
An olfactory neuroblastoma (ONB) originating from olfactory
neuroectoderm is a rare immature tumor showing neuroblas-
tomal, paraganglial and epithelial characteristics.1 We report
a case of ONB that showed neuronal differentiation with
Homer–Wright rosettes and fibrillary background, epithelial
Correspondence: Katsutoshi Miura, MD, Division of Pathology,
Hamamatsu University School of Medicine, 1-20-1 Handa-yama,
Hamamatsu-shi 431-3192, Japan. Email: kmiura@hama-med.ac.jp
Received 26 June 2001. Accepted for publication 14 September
2001.
Ganglioneuroma ex olfactory neuroblastoma 943
lobular growth patterns of cells with oval or elongated, mostly
hyperchromatic nuclei (Fig. 2). The nests of closely packed
cells were intermingled with Homer–Wright rosettes (Fig. 3)
and Flexner–Wintersteiner rosettes with ductal structures
(Fig. 4). No external basement membrane of the rosettes
was seen. Intercellular fibrillar background was found focally.
Mitotic figures and necroses were frequent and vascular
invasion was seen at the tumor margin. No ganglion cells
were found in the biopsy specimen. The histological grade
according to the Hyams grading system was grade 3 (Table
1).
Immunohistochemical studies (Table 2) showed positive
reactions for cytokeratin (CK) (Fig. 5a) and epithelial mem-
brane antigen (EMA) in packed cells forming two types of
Figure 1 Magnetic resonance imaging (MRI) showing a large
tumor occupying the right ethmoidal sinus, extending to the right
sphenoidal sinus and both maxillary sinuses and reaching the frontal
base and orbital wall.
Figure 3 The nests of closely packed cells are intermingled with
Homer–Wright rosettes (black arrow). Mitotic figures (white arrows)
are frequently seen.
Figure 2 Low magnification of the tumor. The tumor is highly cellu-
lar with a lobular growth pattern surrounding the fibrovascular
septum. Tumor cells have oval or elongated, mostly hyperchromatic
nuclei. Focal necrosis can be seen.
Figure 4 Flexner–Wintersteiner rosettes forming ductal structures
are focally found. No external basement membrane is seen.
Table 1 Histological grading of tumors according to the Hyams grading system19
Grade 1 Grade 2 Grade 3 Grade 4 Before therapy
Cytoarchitecture Lobular Lobular ± Lobular ± Lobular Lobular
Mitotic rate 0 Low High High High
Nuclear pleomorphism None Slight Moderate Marked Moderate
Fibrillary background Prominent Present Slight None Slight
Rosettes ± Homer–Wright ± Homer–Wright Flexner None Flexner, Homer–Wright
Necrosis None None Mild Frequent Mild
rosettes. These cells also showed positive reactions for chro-
mogranin A and ADH (Fig. 5b). A faint positive reaction for
neuron-specific enolase (NSE) was present on the fibrillary
structures. Sustentacular cells at the periphery of the cell
nests were focally positive for S-100 protein (S-100). CD99
(MIC2) immunostaining was negative and the Ki-67 (MIB-1)
staining index of the tumor cells was 35.4%.
In the resected specimen after chemoradiotherapy, a resid-
ual tumor was found in the paranasal sinus. Immature tumor
cells with hyperchromatic nuclei were not detected. Large
ganglion-like cells with large round nuclei, open chromatin,
prominent nucleoli and eosinophilic cytoplasm were intermin-
gled with Schwann-like elongated cells (Fig. 6). Some cells
with pyknotic nuclei were surrounded by numerous lympho-
cytes (Fig. 7).
Immunohistochemistry showed that the ganglion-like cells
were positive for neuronal markers including synaptophysin,
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Table 2 Antibodies used in this study
Antigen Source Dilution
Cytokeratin (AE1/AE Biomeda, Foster City, Pre-diluted
3 clone) CA, USA
EMA DAKO, Kyoto, Japan 1 : 100
Chromogranin A DAKO 1 : 100
ADH Chemicon, Temecula, 1 : 1000
CA, USA
NSE Novocastra, Newcastle 1 : 100
Upon Tyne, UK
S-100 DAKO 1 : 500
Ki-67 (MIB-1) Immunotech, Marseilles, 1 : 50
France
Synaptophysin DAKO 1 : 20
Neurofilament DAKO 1 : 100
protein
CD99 (MIC2) Signet, Dedham, MA, 1 : 100
USA
CD3 DAKO 1 : 100
CD20 DAKO Pre-diluted




Figure 5 The tumor cells forming rosettes are positive for (a) cyto-
keratin and (b) antidiuretic hormone.
Figure 6 In the resected specimen following chemoradiotherapy,
residual tumor infiltrating the paranasal sinus is composed of large
ganglion-like cells with round nuclei and Schwann-like elongated
cells.
Figure 7 Lymphocytes are focally infiltrated around tumor cells.
Some ganglion-like cells with round nuclei show pyknotic nuclei.
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neurofilament protein and NSE, while Schwann-like elon-
gated cells were positive for S-100. Focal weak reactivity for
CK was found on small round cells near ganglion-like cells
(Fig. 8). Most infiltrating lymphocytes were positive for CD3
(Fig. 9). CD20 positive cells were rarely seen. The MIB-1
staining index of the residual tumor cells was less than 1%.
DISCUSSION
Our case showed various histological features, including neu-
roblastoma with Homer–Wright rosettes, fibrillary matrix,
Flexner–Wintersteiner rosettes, ADH production and gan-
glioneural differentiation after chemoradiotherapy. This histo-
logical diversity could be a manifestation of the multipotential
nature of olfactory mucosal progenitor cells.2 Tumors arising
from this region of the olfactory mucosa constitute a diverse
group of neoplasms such as ganglioneuroblastoma, paragan-
glioma, esthesioneuroblastoma, olfactory neuroepithelioma,
neuroendocrine carcinoma and sinonasal undifferentiated
carcinoma. These tumors exhibit a wide range of neuronal
and epithelial differentiation. We think these tumors originate
from the mitotically active progenitor cells lying on the basal
layer of the olfactory epithelium.3 During embryonic develop-
ment, the basal cells are thought to be able to differentiate
toward sensory receptor neurons and epithelial sustentacular
cells.1,3 In adults, basal cells supply epithelial sustentacular
cells. Although continuous renewal of olfactory receptor
neurons is known in other mammals,4 it is not known whether
olfactory neuronal cells can regenerate in humans.
Neuroblastoma arising from the adrenal medulla and 
sympathetic ganglia in infants has been known to mature to
ganglioneuroblastoma or ganglioneuroma and then sponta-
neously regress.5,6 ONB differs from neuroblastomas of the
adrenal and sympathetic nervous system in its occurrence in
older patients, distinctive angiomatoid stroma, occasional
olfactory rosette formation and extreme rarity of spontaneous
regression and transformation to ganglion neuroblastoma or
ganglioneuroma.
To explain the spontaneous regression of adrenal neuro-
blastoma in children, three hypotheses have been advanced:
the immunological theory, the delayed apoptosis theory and
the maturation theory. In the immunological theory, the tumor
cells are attacked by the infant’s immune system or by
transplacentally acquired maternal immune cells and mater-
nal antibody7 while in the delayed apoptosis theory, the devel-
opmental time-switch for apoptosis is delayed in tumors.8 In
the maturation theory, immature neuroblastic components
disappear and ganglion cells increase in number and accom-
pany rich Schwannian stroma. Spontaneous maturation of
neuroblastic tumors has been a well-known phenomenon
since early last century.5 Cushing and Wolbach reported a
case of a child with a sympathetic neuroblastoma that was
biopsied in infancy and resected 10 years later, at which time
the tumor was a ganglioneuroma.9 The ganglioneuroma is a
neuroblastoma at the final stage of maturation, and all gan-
glioneuromas were once neuroblastomas at an earlier time in
their development.5
Our ONB case showed maturation to ganglioneuroma at
the primary site after chemoradiotherapy. CD3-positive lym-
phocytic infiltration around the remaining immature epithelial
components of cytokeratin-positive cells suggests that the
process of neuroblastic regression was associated with 
the cytotoxic effects of lymphocytes. T lymphocytes had
probably induced the immature neuroblastic cells to undergo
apoptosis.
Neuroblastomas consist of two main cell populations: neu-
roblastic/ganglionic cells and Schwann cells. Recent genetic
analysis indicates that the Schwann cells in neuroblastic
tumors are likely to be reactive in nature and are recruited
Figure 8 Cytokeratin is positive in the small cells in the vicinity of
the ganglion-like cells.
Figure 9 Infiltrating lymphocytes around ganglion-like cells are
positive for CD3.
from the surrounding non-neoplatic tissues by the tumor
cells.10 This suggests that neoplastic neuroblasts produce
Schwann cell mitogens and chemotactic factors that are
important for the recruitment of Schwann cells.11
Kadish and associates12 have proposed a system that
defines the disease stages as follows: stage A, disease con-
fined to the nasal cavity; stage B, disease confined to the
nasal cavity and paranasal sinuses; and stage C, local or
distant spread beyond the nasal cavity or paranasal sinuses.
The disease incidence is 30% for stage A, 42% for stage B
and 28% for stage C.1 Our case showed stage B at the first
presentation but rapidly progressed to stage C and finally
showed distant metastasis to the mediastinum. Although
ganglioneuroma generally shows good prognoses, this case
presented lymph node and mediastinal metastasis. After
treatment, the primary site had no immature components and
no mitotic activity, with a low MIB-1 staining index. The imma-
ture components had probably metastasized before treat-
ment because vascular invasion had already been found in
the biopsy specimen. Only the primary sites of the nasal and
paranasal cavity were irradiated, not the metastatic sites.
Mature transformation occurred only in the primary site. A few
cases of ONB showed ganglionic differentiation13–18 and two
cases showed abundant ganglion cells after irradiation.16,17
Because the biopsy specimen was limited in amount, it is
possible that ganglion cells were a component of the tumor
from the beginning and that only mature components
remained in the irradiated primary site.
Hyams et al.19 proposed a grading system based on histo-
logical findings (Table 1). According to this system, this case
correlated to a histological grade of 3 before therapy and
showed no characteristics of ONB after chemoradiotherapy.
Examination of the limited data presented in 1983 by Hyams
(assessing 46 tumors from the Armed Forces Institute of
Pathology registry) showed a correlation between tumor
grade and prognosis. With a mean follow up of 5 years, none
of the six patients with grade 1 tumors died of the disease,
while three of the 25 (12%) with grade 2 tumors, six of the 11
(55%) with grade 3 tumors and all four patients with grade 4
tumors died of the disease.19 A recent report supports the pre-
dictive value of this histological grading system.20 Of the six
patients with Hyams grade 1 or 2 tumors, four remained
disease free for more than 2 years compared with only four of
15 patients with Hyams grade 3 or 4 tumors.
Some tumor recurrences are rapid and lethal whereas
others are slow and progressive, with patients surviving for
many years. Fifty to 70% of patients develop local recur-
rence, and 20 to 30% eventually develop distant metasta-
sis.21 A recent study from the University of Iowa reported that
the 5- and 10-year survival rates for ONB were 56 and 42%,
respectively.22
Hirose et al.18 have reported that longer survival rates are
related to a higher incidence of S-100 protein-positive cells
and a low MIB-1 staining index (<10%). Our case exhibited
few S-100 protein-positive cells and a high MIB-1 staining
index (35.4%) at the initial biopsy and followed an unfavor-
able course. Out of the five reported cases of ONB associ-
ated with SIADH,23–28 all cases had Homer–Wright rosettes,
three were accompanied by hypertension and only one
showed true rosette-forming duct-like spaces.27
In conclusion, this case of ONB is an extremely rare case
showing epithelial and endocrine differentiation. These fea-
tures may depend upon the progenitor or basal stem cells of
the olfactory neurons. Pluripotent cells may have been the
origin in our case, and their existence explains why various
neoplasms with neural and epithelial differentiation arise from
the olfactory mucosa.
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